Neurology in Rego Park, NY
8 verified neurology doctors in Rego Park.
Neurologists diagnose and treat disorders of the brain, spinal cord, and nervous system, such as migraines, epilepsy, and stroke.
NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.
Verify a license at the New York State Board for Professional Medical Conduct
Dr. Maia Batash, MD
Neurology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Dora Pinkhasova, MD
Neurology
CMS Open Payments· $44.28 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$44.28
Total received
2
Transactions
1
Paying companies
Top paying companies
Among the 22,669 neurology doctors we've analyzed, about 51% received any industry payment (median $640 among those who did). This doctor's total ranks around the 55th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US neurology doctors.
Payments to Dora Pinkhasova do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Andre Strizhak, MD
Neurology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Igor Cohen, MD
Neurology
CMS Open Payments· $618.82 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$618.82
Total received
29
Transactions
4
Paying companies
Top paying companies
Among the 22,669 neurology doctors we've analyzed, about 51% received any industry payment (median $640 among those who did). This doctor's total ranks around the 74th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US neurology doctors.
Payments to Igor Cohen do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Vladimir Zlatnik, MD
Neurology
CMS Open Payments· $510.70 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$510.70
Total received
22
Transactions
7
Paying companies
Top paying companies
Among the 22,669 neurology doctors we've analyzed, about 51% received any industry payment (median $640 among those who did). This doctor's total ranks around the 73th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US neurology doctors.
Payments to Vladimir Zlatnik do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Dmitriy Kolesnik, MD
Neurology
CMS Open Payments· $1,537 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$1,537
Total received
75
Transactions
17
Paying companies
Top paying companies
Among the 22,669 neurology doctors we've analyzed, about 51% received any industry payment (median $640 among those who did). This doctor's total ranks around the 81th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US neurology doctors.
Payments to Dmitriy Kolesnik do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Tatyana Yuzbashyan, MD
Neurology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Steven Xian, MD
Neurology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.